30 results match your criteria: "Shakomae Kokorono Clinic[Affiliation]"
Continuation rate for asenapine and brexpiprazole treatment in elderly patients with schizophrenia.
Psychogeriatrics
November 2021
Department of Psychiatry, Course of Specialised Clinical Science, Tokai University School of Medicine, Isehara, Japan.
Continuation rate for asenapine and brexpiprazole treatment in patients with schizophrenia.
Brain Behav
May 2021
Department of Psychiatry, Course of Specialized Clinical Science, Tokai University School of Medicine, Kanagawa, Japan.
Introduction: The current study sought to compare the treatment continuation rates of asenapine and brexpiprazole while specifically investigating the factors influencing this index and the clinical efficacy of brexpiprazole.
Methods: Retrospective study on patients with schizophrenia who were prescribed either asenapine (n = 73) or brexpiprazole (n = 136), as part of their routine medical care.
Results: The treatment continuation rates for asenapine and brexpiprazole were 19.
Benefit of extending the dosing interval of long-acting injection in maintenance treatment of outpatients with schizophrenia.
Asian J Psychiatr
February 2020
Department of Psychiatry, Shakomae Kokorono Clinic, Tokyo, 116-0011, Japan.
The effect of aripiprazole once-monthly 300 mg in maintenance therapy for schizophrenia.
Asian J Psychiatr
January 2020
Department of Psychiatry, Shakomae Kokorono Clinic [Y.I.], Tokyo, 116-0011, Japan.
Comparisons of the effects of long-acting injectable monotherapy and combination therapy of long-acting injectable treatment with oral antipsychotics on treatment retention in patients with chronic schizophrenia.
Asian J Psychiatr
January 2019
Department of Psychiatry, Fukui Kinen Hospital [H.H.], [A.T], Kanagawa 238-0115, Japan.
Mortality rate is associated with aripiprazole once-monthly and oral asenapine administration.
Asian J Psychiatr
January 2019
Department of Psychiatry, Fukui Kinen Hospital, Kanagawa 238-0115, Japan.
Treatment Continuation of 3 Second-Generation Antipsychotic Long-Acting Injections, and Oral Paliperidone in Patients With Schizophrenia for 2 Years.
J Clin Psychopharmacol
December 2018
Department of Psychiatry, Suzuki Clinic Tokyo, Japan Department of Psychiatry, Fukui Kinen Hospital, Kanagawa, Japan Department of Psychiatry, Shakomae Kokorono Clinic, Tokyo, Japan Department of Psychiatry, Fukui Kinen Hospital, Kanagawa, Japan.
Comparisons of the effects of second-generation antipsychotics long-acting injections on treatment retention according to severity of patient condition.
Asian J Psychiatr
October 2018
Department of Psychiatry, Fukui Kinen Hospital [H.H.], [A.T], Kanagawa 238-0115, Japan.
Introduction: There have been no naturalistic reports in Japan clarifying the difference of second-generation antipsychotics (SGA) long-acting injections (LAIs) on treatment retention according to severity of patient condition.
Methods: This study aimed to investigate the difference in treatment retention between SGA LAIs according to severity of patient condition.
Results: This study demonstrated that, although AOM patients had better rates of treatment retention compared to PP and RLAI for mild cases, the reverse was true for moderate to severe cases.
Mortality rate is associated with paliperidone palmitate, risperidone long-acting injection, and oral paliperidone administration.
Asian J Psychiatr
June 2018
Department of Psychiatry, Fukui Kinen Hospital [H.H.], [A.T], Kanagawa 238-0115, Japan.
Changes in length of hospital stay and number of hospitalization before and after the administration of three second-generation antipsychotics long-acting injections in patients with schizophrenia: Mirror-image study.
Asian J Psychiatr
April 2018
Department of Psychiatry, Fukui Kinen Hospital, Kanagawa 238-0115, Japan.
The advantages of introducing aripiprazole once-monthly 300 mg in the bipolar disorder-II maintenance treatment regime for 2 patients.
Asian J Psychiatr
April 2018
Department of Psychiatry, Tokai University School of Medicine, Kanagawa, 259-1193, Japan.
Effect of aripiprazole monotherapy in a patient presenting with delayed sleep phase syndrome associated with depressive symptoms.
Psychiatry Clin Neurosci
May 2018
Department of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.
Factors related to the continuation of aripiprazole once-monthly treatment at 1 year.
Asian J Psychiatr
January 2018
Department of Psychiatry, Fukui Kinen Hospital, Kanagawa 238-0115, Japan.
One patient with schizophrenia showed reduced drug-induced extrapyramidal symptoms as a result of an alternative regimen of treatment with paliperidone 3 and 6 mg every other day.
SAGE Open Med Case Rep
December 2017
Department of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.
Background: Schizophrenia is a chronic disease that requires long-term management with antipsychotics. Antipsychotic drugs are given by tapering their dose, extending the dosing interval, and so on, as part of a treatment strategy to minimize the adverse effects while at the same time maintaining efficacy.
Methods: We report the case of one patient with schizophrenia in whom the clinical symptoms were alleviated after treatment with 6 mg paliperidone.
The benefits of the concomitant use of antidepressants and acetyl-l-carnitine in the treatment of moderate depression.
Asian J Psychiatr
March 2019
Department of Psychiatry, Tokai University School of Medicine, Kanagawa 259-1193, Japan.
Effect of acetyl-l-carnitine in elderly patient who presented with hyperammonemia associated with administration of sodium valproate.
Asian J Psychiatr
December 2017
Department of Psychiatry, Suzuki Clinic [H.S.], Tokyo 168-0065, Japan; Department of Psychiatry, Fukui Kinen Hospital [H.H.], Kanagawa 238-0115, Japan; Department of Psychiatry, Shakomae Kokorono Clinic [Y.I.], Tokyo 116-0011, Japan; Department of Data Science, Center for Clinical Science, National Center for Global Health and Medicine [A.M], Tokyo 162-8655, Japan; Department of Psychiatry, Tokai University School of Medicine [H.M.], [K.M], Kanagawa 259-1193, Japan.
Benefits associated with switching from benzodiazepine hypnotics to suvorexant in patients with mild primary insomnia.
Asian J Psychiatr
October 2017
Department of Psychiatry, Tokai University School of Medicine, Kanagawa 259-1193, Japan.
Benefits of switching to suvorexant for mild primary insomnia when sleepwalking episodes occur during zolpidem treatment.
Asian J Psychiatr
December 2017
Department of Psychiatry, Suzuki Clinic, 3-34-16 Hamadayama, Suginami, Tokyo 168-0065, Japan; Department of Psychiatry, Fukui Kinen Hospital, Kanagawa 238-0115, Japan; Department of Psychiatry, Shakomae Kokorono Clinic, Tokyo 116-0011, Japan; Department of Data Science, Center for Clinical Science, National Center for Global Health and Medicine, Tokyo 162-8655, Japan; Department of Psychiatry, Tokai University School of Medicine, Kanagawa 259-1193, Japan.
Benefit of extending the dosing interval of olanzapine on schizophrenics during maintenance treatment.
Asian J Psychiatr
December 2017
Department of Psychiatry, Tokai University School of Medicine, Kanagawa 259-1193, Japan.
Benefit of extending the dosing interval of paliperidone palmitate on schizophrenics with mild cognitive dysfunction.
Asian J Psychiatr
August 2017
Department of Psychiatry, Tokai University School of Medicine [H.M.], [K.M], Kanagawa 259-1193, Japan.
Reduced insomnia following short-term administration of suvorexant during aripiprazole once-monthly treatment in a patient with schizophrenia.
Asian J Psychiatr
August 2017
Department of Psychiatry, Tokai University School of Medicine, Kanagawa 259-1193, Japan.
The effect of switching from oral low-dose aripiprazole to aripiprazole once-monthly 300 mg on the quality of life in three patients with schizophrenia.
SAGE Open Med Case Rep
May 2017
Department of Psychiatry, School of Medicine, Tokai University, Kanagawa, Japan.
Background: Schizophrenia is a chronic disease that requires long-term management with antipsychotics; however, an important barrier to the success of long-term treatment is drug noncompliance, which increases the risk of recurrence and hospitalization. Second-generation long-acting injectable antipsychotics have improved drug adherence, and the pharmacological effects of the drugs, and therefore, have become useful treatment options.
Methods: We report on three schizophrenia patients who switched from oral low-dose aripiprazole to aripiprazole once-monthly 300 mg.
Treatment retention of risperidone long-acting injection in patients with early-onset schizophrenia in Japan.
Asian J Psychiatr
June 2017
Department of Psychiatry, Fukui Kinen Hospital [H.H.], [A.T], Kanagawa 238-0115, Japan.
Assessments of plasma concentrations, pathology symptoms, and cognition following paliperidone treatment in schizophrenic patients previously treated with risperidone.
Asian J Psychiatr
April 2017
Department of Psychiatry, Tokai University School of Medicine, Kanagawa 259-1193, Japan.
Benefit of extending the dosing interval of long-acting antipsychotic injections in elderly schizophrenics with cognitive dysfunction.
Psychogeriatrics
November 2017
Department of Psychiatry, Tokai University School of Medicine, Kanagawa, Japan.